Luteolin and abyssinone II as potential inhibitors of SARS-CoV-2: an in silico molecular modeling approach in battling the COVID-19 outbreak
Research
[키워드] Absorption
Abyssinone II
Accuracy
Analysis
antiviral activity
approach
AutoDock
binding
binding free energy
binding site
bioinformatics
candidate
carried
clinically
combating
complex
complexes
Compound
conducted
contagious
COVID-19
COVID-19 outbreak
COVID-19 pandemic
death
determine
develop
deviation
docked
docking
Efficiency
evaluated
excretion
flavonoids
fluctuation
Healthcare system
Homo sapien
in silico
in vitro experiments
Infection
inhibitor
Interaction
lack
Ligand
lowest
Luteolin
mechanism of action
molecular
molecular docking
Molecular dynamics simulation
molecular target
pandemic
pathogenic
recorded
Research
Result
resulting
Safe
SARS-CoV-2
SARS-COV-2 infection
Screening
selected
target protein
target proteins
therapeutic
therapeutic intervention
Treatment
was done
[DOI] 10.1186/s42269-020-00479-6 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s42269-020-00479-6 PMC 바로가기 [Article Type] Research